Synthetic fractals inherently carry spatially encoded frequency information that renders them as an ideal candidate for broadband optical structures. Nowhere is this more true than in the terahertz (THz) band where there is a lack of naturally occurring materials with valuable optical properties. One example are perfect absorbers that are a direct step toward the development of highly sought after detectors and sensing devices. Metasurface absorbers that can be used to substitute for natural materials suffer from poor broadband performance, while those with high absorption and broadband capability typically involve complex fabrication and design and are multilayered. Here, we demonstrate a polarization-insensitive ultrathin (∼λ/6) planar metasurface THz absorber composed of supercells of fractal crosses capable of spanning one optical octave in bandwidth, while still being highly efficient. A sufficiently thick polyimide interlayer produces a unique absorption mechanism based on Salisbury screen and antireflection responses, which lends to the broadband operation. Experimental peak absorption exceeds 93%, while the average absorption is 83% from 2.82 THz to 5.15 THz. This new ultrathin device architecture, achieving an absorption-bandwidth of one optical octave, demonstrates a major advance toward a synthetic metasurface blackbody absorber in the THz band.
For a 2-mg labelled nominal dose of fluticasone, the spacer produced about a sevenfold higher relative lung dose than the nebuliser. This suggests that a very little of the labelled nebulised dose is respirable. Other factors such as patient preference, cost and compliance will determine the inhaler device that is chosen.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.